Learn More

Sign UpBecome A Provider

Learn MoreAbout EarlyCDT-Lung

Learn MorePhysicians Testimonials

Find OutSee who is involved with EarlyCDT-Lung

A simple blood test to aid in the
early detection of lung cancer.

Your Challenge

How to identify the relatively small percentage of lung cancers (5-50 depending on the level of risk), per 1,000, that are present in your high-risk patient population. Watch overview webcast.

FACTS:

• EarlyCDT-Lung, a simple blood test, measures a panel of autoantibodies that develop in response to tumor associated antigens. View article.
• The presence of autoantibodies to tumor antigens have been reported to be detectable to 5 years before a tumor becomes definable. View article.
• EarlyCDT-Lung has excellent performance. View article.

Click image to download a Wall Chart

USE OF EarlyCDT-Lung:

• As a risk assessment test to aid in the early detection of lung cancer in your high-risk asymptomatic patients. See overview.
• Independent biological tool to assist in pulmonary nodule determination. See overview.

HOW:

• EarlyCDT-Lung detects antibodies that develop in response to tumor associated proteins.